Vesicular Sézary syndrome with bullous lesions on the feet.
Dehesa
Luis
L
Bastida
Jesús
J
Camacho-Galán
Rafael
R
Campos-Adsuar
Conrado
C
Gómez-Duaso
Javier
J
Vilar-Alejo
Jaime
J
D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols; D001768:Blister / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D005260:Female; D005533:Foot Dermatoses / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D012751:Sezary Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone